Skip to main content
Top
Published in: Archives of Osteoporosis 1/2021

01-12-2021 | Bisphosphonate | Original Article

Consensus evidence-based clinical practice guidelines for the diagnosis and treat-to-target management of osteoporosis in Africa: an initiative by the African Society of Bone Health and Metabolic Bone Diseases

Authors: Y El Miedany, Farhanah Paruk, Asgar Kalla, A. Adebajo, Maha El Gaafary, Abdellah El Maghraoui, Madeleine Ngandeu, Dzifa Dey, Naglaa Gadallah, Mohamed Elwy, Farzana Moosajee, Mohammed Hassan Abu-Zaid, Salwa Galal, Soussen Miladi, Waleed Hassan, Abubaker Fadlelmola, Sally Saber

Published in: Archives of Osteoporosis | Issue 1/2021

Login to get access

Abstract

Summary

The objective of this consensus statement is to inform the clinical practice communities, research centres and policymakers across Africa of the results of the recommendations for osteoporosis prevention, diagnosis and management. The developed guideline provides state-of-the-art information and presents the conclusions and recommendations of the consensus panel regarding these issues.

Purpose

To reach an African expert consensus on a treat-to-target strategy, based on current evidence for best practice, for the management of osteoporosis and prevention of fractures.

Method

A 3-round Delphi process was conducted with 17 osteoporosis experts from different African countries. All rounds were conducted online. In round 1, experts reviewed a list of 21 key clinical questions. In rounds 2 and 3, they rated the statements stratified under each domain for its fit (on a scale of 1–9). After each round, statements were retired, modified or added in view of the experts’ suggestions and the percent agreement was calculated. Statements receiving rates of 7–9 by more than 75% of experts’ votes were considered as achieving consensus.

Results

The developed guidelines adopted a fracture risk-centric approach. Results of round 1 revealed that of the 21 proposed domains, 10 were accepted whereas 11 were amended. In round 2, 32 statements were presented: 2 statements were retired for similarity, 9 statements reached consensus, whereas modifications were suggested for 21 statements. After the 3rd round of rating, the experts came to consensus on the 32 statements. Frequency of high-rate recommendation ranged from 83.33 to 100%. The response rate of the experts was 100%. An algorithm for the osteoporosis management osteoporosis was suggested.

Conclusion

This study is an important step in setting up a standardised osteoporosis service across the continent. Building a single model that can be applied in standard practice across Africa will enable the clinicians to face the key challenges of managing osteoporosis; furthermore, it highlights the unmet needs for the policymakers responsible for providing bone health care together with and positive outcomes of patients’ care.
Literature
2.
go back to reference Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733CrossRef Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733CrossRef
3.
go back to reference Kanis J, Johnell O, Oden A, Sernbo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B (2000) Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11:669–674CrossRef Kanis J, Johnell O, Oden A, Sernbo I, Redlund-Johnell I, Dawson A, De Laet C, Jonsson B (2000) Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11:669–674CrossRef
4.
go back to reference Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427CrossRef Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427CrossRef
5.
go back to reference Rashki Kemmak A, Rezapour A, Jahangiri R, Nikjoo S, Farabi H, Soleimanpour S (2020) Economic burden of osteoporosis in the world: a systematic review. Med J Islam Repub Iran 34:154PubMedPubMedCentral Rashki Kemmak A, Rezapour A, Jahangiri R, Nikjoo S, Farabi H, Soleimanpour S (2020) Economic burden of osteoporosis in the world: a systematic review. Med J Islam Repub Iran 34:154PubMedPubMedCentral
6.
go back to reference Handa R, Kalla AA, Maalouf G (2008) Osteoporosis in developing countries. Best Pract Res Clin Rheumatol 22:693–708CrossRef Handa R, Kalla AA, Maalouf G (2008) Osteoporosis in developing countries. Best Pract Res Clin Rheumatol 22:693–708CrossRef
7.
go back to reference Paruk F, Tsabasvi M, Kalla AA (2021) Osteoporosis in Africa—where are we now. Clin Rheumatol 40(9):3419–3428CrossRef Paruk F, Tsabasvi M, Kalla AA (2021) Osteoporosis in Africa—where are we now. Clin Rheumatol 40(9):3419–3428CrossRef
8.
go back to reference Billek-Sawhney B (2019) Osteoporosis risk – think twice about bone density in Ethiopians African Americans. Int Phys Med Rehab J 4(3):91–94 Billek-Sawhney B (2019) Osteoporosis risk – think twice about bone density in Ethiopians African Americans. Int Phys Med Rehab J 4(3):91–94
12.
go back to reference Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W65-94CrossRef Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W65-94CrossRef
13.
go back to reference Leclercq E, Leeflang MM, van Dalen EC, Kremer LC (2013) Validation of search filters for identifying pediatric studies. J Pediatr 162:629–634CrossRef Leclercq E, Leeflang MM, van Dalen EC, Kremer LC (2013) Validation of search filters for identifying pediatric studies. J Pediatr 162:629–634CrossRef
14.
go back to reference OCEBM Levels of Evidence Working Group (2011) The Oxford levels of evidence 2. Oxford Centre for Evidence-Based Medicine, Oxford OCEBM Levels of Evidence Working Group (2011) The Oxford levels of evidence 2. Oxford Centre for Evidence-Based Medicine, Oxford
15.
go back to reference Von der Gracht H (2012) Consensus measurement in Delphi studies: review and implications for future quality assurance. Technol Forecast Soc 79(8):1525–1536CrossRef Von der Gracht H (2012) Consensus measurement in Delphi studies: review and implications for future quality assurance. Technol Forecast Soc 79(8):1525–1536CrossRef
16.
go back to reference Rowe G, Wright G (1999) The Delphi technique as a forecasting tool: issues and analysis. Int J Forecast 15:353–375CrossRef Rowe G, Wright G (1999) The Delphi technique as a forecasting tool: issues and analysis. Int J Forecast 15:353–375CrossRef
17.
go back to reference Rayens MK, Hahn EJ (2000) Building consensus using the policy Delphi method. Policy Polit Nurs Pract 1(4):308–315CrossRef Rayens MK, Hahn EJ (2000) Building consensus using the policy Delphi method. Policy Polit Nurs Pract 1(4):308–315CrossRef
18.
go back to reference Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, Wales PW (2014) Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol 67(4):401–409CrossRef Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, Wales PW (2014) Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol 67(4):401–409CrossRef
19.
go back to reference Kanis JA, Johansson H, Oden A, McCloskey EV (2011) Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 22:809–816CrossRef Kanis JA, Johansson H, Oden A, McCloskey EV (2011) Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 22:809–816CrossRef
20.
go back to reference Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, Wiessing KR, Bolland MJ, Bastin S, Gamble GD (2018) Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med 379(25):2407–2416CrossRef Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, Wiessing KR, Bolland MJ, Bastin S, Gamble GD (2018) Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med 379(25):2407–2416CrossRef
21.
go back to reference Kinsella K, Wan H. An aging world: 2008. U.S. Census Bureau. International Population Reports. 2009; 9(1): 9 Kinsella K, Wan H. An aging world: 2008. U.S. Census Bureau. International Population Reports. 2009; 9(1): 9
22.
go back to reference Gheita T, Hammam N (2018) Epidemiology and awareness of osteoporosis: a viewpoint from the Middle East and North Africa. Int J Clin Rheumatol 13(3):134–147 Gheita T, Hammam N (2018) Epidemiology and awareness of osteoporosis: a viewpoint from the Middle East and North Africa. Int J Clin Rheumatol 13(3):134–147
23.
go back to reference Ouzzif Z, Oumghar K, Sbai K et al (2012) Relation of plasma total homocysteine, folate and vitamin B12 levels to bone mineral density in Moroccan healthy postmenopausal women. Rheumatol Int 32(1):123–8CrossRef Ouzzif Z, Oumghar K, Sbai K et al (2012) Relation of plasma total homocysteine, folate and vitamin B12 levels to bone mineral density in Moroccan healthy postmenopausal women. Rheumatol Int 32(1):123–8CrossRef
24.
go back to reference El Maghraoui A, Sadni S, El Maataoui A, Majjad A, Rezqi A, Ouzzif Z, Mounach A (2015) Influence of obesity on vertebral fracture prevalence and vitamin D status in postmenopausal women. Nutr Metab (Lond) 14(12):44CrossRef El Maghraoui A, Sadni S, El Maataoui A, Majjad A, Rezqi A, Ouzzif Z, Mounach A (2015) Influence of obesity on vertebral fracture prevalence and vitamin D status in postmenopausal women. Nutr Metab (Lond) 14(12):44CrossRef
25.
go back to reference Ben Aissa R, Laatar A, Kerkeni S et al (2006) Prévalence de Et, l’ostéoporose chez les femmes ménopausées des gouvernorats de l’Ariana 119, de la Manouba-Tunis. Tun. Méd. 84(Suppl 10) Ben Aissa R, Laatar A, Kerkeni S et al (2006) Prévalence de Et, l’ostéoporose chez les femmes ménopausées des gouvernorats de l’Ariana 119, de la Manouba-Tunis. Tun. Méd. 84(Suppl 10)
26.
go back to reference Haouichat C, Hammoumraoui N, Lehtihet S et al (2014) SAT0461 Prevalence of postmenopausal osteoporosis in Algerian women. Ann Rheum Dis 73:760CrossRef Haouichat C, Hammoumraoui N, Lehtihet S et al (2014) SAT0461 Prevalence of postmenopausal osteoporosis in Algerian women. Ann Rheum Dis 73:760CrossRef
27.
go back to reference Paruk F, Matthews G, Cassim B (2017) Osteoporotic hip fractures in Black South Africans: a regional study. Arch Osteoporos 12(1):107CrossRef Paruk F, Matthews G, Cassim B (2017) Osteoporotic hip fractures in Black South Africans: a regional study. Arch Osteoporos 12(1):107CrossRef
28.
go back to reference Cauley JA, Wu L, Wampler NS et al (2007) Clinical risk factors for fractures in multi-ethnic women. the women’s health initiative. J Bone Miner Res 22:1816–1826CrossRef Cauley JA, Wu L, Wampler NS et al (2007) Clinical risk factors for fractures in multi-ethnic women. the women’s health initiative. J Bone Miner Res 22:1816–1826CrossRef
29.
go back to reference Peled R, Dahan D, Endevelt R et al (2007) Osteoporosis among Ethiopian immigrant women: a risk analysis. Arch Osteoporos 2:45–52CrossRef Peled R, Dahan D, Endevelt R et al (2007) Osteoporosis among Ethiopian immigrant women: a risk analysis. Arch Osteoporos 2:45–52CrossRef
31.
go back to reference Amod A, Ascott-Evans B, Brown S, Cassim B, Davey M, de Lange W, de Villiers T et al (2017) South African clinical guideline for the diagnosis and management of osteoporosis: JEMDSA 2017; 22(1) (Supplement 1) Amod A, Ascott-Evans B, Brown S, Cassim B, Davey M, de Lange W, de Villiers T et al (2017) South African clinical guideline for the diagnosis and management of osteoporosis: JEMDSA 2017; 22(1) (Supplement 1)
32.
go back to reference Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB (2020) American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26(Suppl 1):1–46CrossRef Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB (2020) American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26(Suppl 1):1–46CrossRef
33.
go back to reference Kanis J, Cooper C, Rizzoli R et al (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3–44CrossRef Kanis J, Cooper C, Rizzoli R et al (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3–44CrossRef
34.
go back to reference Meeta M, Harinarayan CV, Marwah R, Sahay R, Kalra S, Babhulkar S (2020) Clinical practice guidelines on postmenopausal osteoporosis: *an executive summary and recommendations - update 2019–2020. J Midlife Health 11(2):96–112PubMedPubMedCentral Meeta M, Harinarayan CV, Marwah R, Sahay R, Kalra S, Babhulkar S (2020) Clinical practice guidelines on postmenopausal osteoporosis: *an executive summary and recommendations - update 2019–2020. J Midlife Health 11(2):96–112PubMedPubMedCentral
35.
go back to reference Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 104(5):1595–1622CrossRef Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 104(5):1595–1622CrossRef
38.
go back to reference Atiase Y, Quarde A (2020) A call to action for osteoporosis research in sub-Saharan Africa. Ghana Med J 54(1):58–67CrossRef Atiase Y, Quarde A (2020) A call to action for osteoporosis research in sub-Saharan Africa. Ghana Med J 54(1):58–67CrossRef
39.
go back to reference Lewiecki EM (2017) Osteoporosis: Treat-to-Target. Curr Osteoporos Rep 15(2):103–109CrossRef Lewiecki EM (2017) Osteoporosis: Treat-to-Target. Curr Osteoporos Rep 15(2):103–109CrossRef
40.
go back to reference Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) Does osteoporosis therapy invalidate FRAX for fracture prediction? J Bone Miner Res 27:1243–1251CrossRef Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) Does osteoporosis therapy invalidate FRAX for fracture prediction? J Bone Miner Res 27:1243–1251CrossRef
41.
go back to reference El Miedany YE, Gaafary ME, Yassaki AE, Youssef S, Nasr A, Ahmed I (2014) Monitoring osteoporosis therapy: can FRAX help assessing success or failure in achieving treatment goals? World J Rheumatol 4(2):14–21CrossRef El Miedany YE, Gaafary ME, Yassaki AE, Youssef S, Nasr A, Ahmed I (2014) Monitoring osteoporosis therapy: can FRAX help assessing success or failure in achieving treatment goals? World J Rheumatol 4(2):14–21CrossRef
42.
go back to reference Kanis JA, Harvey NC, McCloskey E et al (2020) Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int 31:1–12CrossRef Kanis JA, Harvey NC, McCloskey E et al (2020) Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int 31:1–12CrossRef
43.
go back to reference Lewiecki EM (2010) Bone density testing to monitor osteoporosis therapy in clinical practice. Am Fam Physician 82(7):749–754PubMed Lewiecki EM (2010) Bone density testing to monitor osteoporosis therapy in clinical practice. Am Fam Physician 82(7):749–754PubMed
44.
go back to reference Lewiecki EM, Watts NB (2008) Assessing response to osteoporosis therapy. Osteoporos Int 19(10):1363–1368CrossRef Lewiecki EM, Watts NB (2008) Assessing response to osteoporosis therapy. Osteoporos Int 19(10):1363–1368CrossRef
45.
go back to reference Nogués X, Nolla JM, Casado E, Jódar E, Muñoz-Torres M, Quesada-Gómez JM, Canals L, Balcells M, Lizán L (2018) Spanish consensus on treat to target for osteoporosis. Osteoporos Int 29(2):489–499CrossRef Nogués X, Nolla JM, Casado E, Jódar E, Muñoz-Torres M, Quesada-Gómez JM, Canals L, Balcells M, Lizán L (2018) Spanish consensus on treat to target for osteoporosis. Osteoporos Int 29(2):489–499CrossRef
Metadata
Title
Consensus evidence-based clinical practice guidelines for the diagnosis and treat-to-target management of osteoporosis in Africa: an initiative by the African Society of Bone Health and Metabolic Bone Diseases
Authors
Y El Miedany
Farhanah Paruk
Asgar Kalla
A. Adebajo
Maha El Gaafary
Abdellah El Maghraoui
Madeleine Ngandeu
Dzifa Dey
Naglaa Gadallah
Mohamed Elwy
Farzana Moosajee
Mohammed Hassan Abu-Zaid
Salwa Galal
Soussen Miladi
Waleed Hassan
Abubaker Fadlelmola
Sally Saber
Publication date
01-12-2021
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2021
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-021-01035-z

Other articles of this Issue 1/2021

Archives of Osteoporosis 1/2021 Go to the issue